Multiple regulatory inputs converge on cortactin to control invadopodia biogenesis and extracellular matrix degradation

Journal of Cell Science

Volumn 121, Issue 3, 2008, Pages 369-378

  Ayala, Inmaculada ^a   Baldassarre, Massimiliano ^a,d   Giacchetti, Giada ^a   Caldieri, Giusi ^a   Tetè, Stefano ^b   Luini, Alberto ^c   Buccione, Roberto ^a  

^a Tumour Cell Invasion Laboratory   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c Department of Cell Biology and Oncology   (Italy)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cortactin; Invadopodia; Invasion; Protein kinases

Indexed keywords

ACTIN RELATED PROTEIN 2-3 COMPLEX; CORTACTIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEURAL WISKOTT ALDRICH SYNDROME PROTEIN; P21 ACTIVATED KINASE 1; PROTEIN SH3; PROTEIN TYROSINE KINASE;

ACTIN POLYMERIZATION; ARTICLE; BIOGENESIS; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CELL FUNCTION; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL STRUCTURE; CELL SYNCHRONIZATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; INVADOPODIA; MELANOMA CELL; MEMBRANE STRUCTURE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MICROARRAY; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; RNA INTERFERENCE;

ACTIN-RELATED PROTEIN 2-3 COMPLEX; ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; CELL SURFACE EXTENSIONS; CORTACTIN; DNA PRIMERS; EXTRACELLULAR MATRIX; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MELANOMA; NEOPLASM INVASIVENESS; P21-ACTIVATED KINASES; PROTEIN STRUCTURE, TERTIARY; RATS; RECOMBINANT PROTEINS; RNA INTERFERENCE; SRC HOMOLOGY DOMAINS; SRC-FAMILY KINASES; WISKOTT-ALDRICH SYNDROME PROTEIN, NEURONAL;

EID: 40549089536     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.008037     Document Type: Article

References (74)

1. Artym, V. V., Kindzelskii, A. L., Chen, W. T. and Petty, H. R. (2002). Molecular proximity of seprase and the urokinase-type plasminogen activator receptor on malignant melanoma cell membranes: dependence on betal integrins and the cytoskeleton. Carcinogenesis 23, 1593-1601.
2. Artym, V. V., Zhang, Y., Sefillier-Moiseiwitsch, F., Yamada, K. M. and Mueller, S. C. (2006). Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res. 66, 3034-3043.
3. Balasenthil, S., Sahin, A. A., Barnes, C. J., Wang, R. A., Pestell, R. G., Vadlamudi, R. K. and Kumar, R. (2004). p21-activated kinase-1 signaling mediates cyclin D1 expression in mammary epithelial and cancer cells. J. Biol. Chem. 279, 1422-1428.
4. Baldassarre, M., Pompeo, A., Beznoussenko, G., Castaldi, C., Cortellino, S., McNiven, M. A., Luini, A. and Buccione, R. (2003). Dynamin participates in focal extracellular matrix degradation by invasive cells. Mol. Biol. Cell 14, 1074-1084.
5. Baldassarre, M., Ayala, L., Beznoussenko, G., Giacchetti, G., Machesky, L. M., Luini, A. and Buccione, R. (2006). Actin dynamics at sites of extracellular matrix degradation. Eur. J. Cell Biol. 85, 1217-1231.
6. Bekri, S., Adelaide, J., Merscher, S., Grosgeorge, J., Caroli-Bose, F., Perucca-Lostanlen, D., Kelley, P. M., Pebusque, M. J., Theillet, C., Birnbaum, D. et al. (1997). Detailed map of a region commonly amplified at 11q13->q14 in human breast carcinoma. Cytogenet. Cell Genet. 79, 125-131.
7. Bokoch, G. M. (2003). Biology of the p21-activated kinases. Annu. Rev. Biochem. 72,743-781.
8. Bowden, E. T., Barth, M., Thomas, D., Glazer, R. I. and Mueller, S. C. (1999). An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation. Oncogene 18, 4440-4449.
9. Bowden, E. T., Coopman, P. J. and Mueller, S. C. (2001). Invadopodia: unique methods for measurement of extracellular matrix degradation in vitro. Methods Cell Biol. 63, 613-627.
10. Bowden, E. T., Onikoyi, E., Slack, R., Myoui, A., Yuneda, T., Yamada, K. M. and Mueller, S. C. (2006). Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells. Exp, Cell Res. 312, 1240-1253.
11. Boyle, S. N., Michaud, G. A., Schweitzer, B., Predki, P. F. and Koleske, A. J. (2007). A critical role for cortactin phosphorylation by Abl-family kinases in PDGF-induced dorsal-wave formation. Carr. Biol. 17, 445-451.
12. Bringuier, P. P., Tamimi, Y., Schuuring, E. and Schalken, J. (1996). Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification. Oncogene 12, 1747-1753.
13. Brown, P. D. (1995). Matrix metalloproteinase inhibitors: a novel class of anticancer agents. Adv. Enzyme Regul. 35, 293-301.
14. Brown, P. D. and Giavazzi, R. (1995). Matrix metalloproteinase inhibition: a review of anti-tumour activity. Ann. Oncol. 6, 967-974.
15. Buccione, R., Orth, J. D. and McNiven, M. A. (2004). Foot and mouth: podosomes, invadopodia and circular dorsal ruffles. Nat. Rev. Mol. Cell Biol. 5, 647-657.
16. Campbell, D. H., Sutherland, R. L. and Daly, R. J. (1999). Signaling pathways and structural domains required for phosphorylation of EMS1/cortactin. Cancer Res. 59, 5376-5385.
17. Cao, H., Weller, S., Orth, J. D., Chen, J., Huang, B., Chen, J. L., Stamnes, M. and McNiven, M. A. (2005). Actin and Arf1-dependent recruitment of a cortactin-dynamin complex to the Golgi regulates post-Golgi transport. Nat. Cell Biol. 7, 483-492.
18. Carter, J. H., Douglass, L. E., Deddens, J. A., Colligan, B. M., Bhatt, T. R., Pemberton, J. O., Konicek, S., Hom, J., Marshall, M. and Graff, J. R. (2004). Pak-1 expression increases with progression of colorectal carcinomas to metastasis. Clin. Cancer Res. 10, 3448-3456.
19. Chen, W. T. (1989). Proteolytic activity of specialized surface protrusions formed at rosette contact sites of transformed cells. J. Exp. Zool. 251, 167-185.
20. Chen, W. T. (1996). Proteases associated with invadopodia, and their role in degradation of extracellular matrix. Enzyme Protein 49, 59-71.
21. Clark, E. S., Whigham, A. S., Yarbrough, W. G. and Weaver, A. M. (2007). Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Cancer Res. 67, 4227-4235.
22. Egile, C., Rouiller, L, Xu, X. P., Volkmann, N., Li, R. and Hanein, D. (2005). Mechanism of filament nucleation and branch stability revealed by the structure of the Arp2/3 complex at actin branch junctions. PLoS Biol. 3, e383.
23. Eiseler, T., Schmid, M. A., Topbas, F., Pfizenmaier, K. and Hausser, A. (2007). PKD is recruited to sites of actin remodelling at the leading edge and negatively regulates cell migration. FEBS Lett. 581, 4279-4287.
24. Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, W. S., Van Dyk, D. E., Pitts, W. J., Earl, R. A., Hobbs, F. et al. (1998). Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273, 18623-18632.
25. Hashimoto, S., Onodera, Y., Hashimoto, A., Tanaka, M., Hamaguchi, M., Yamada, A. and Sabe, H. (2004). Requirement for Arf6 in breast cancer invasive activities. Proc. Natl. Acad. Sci. USA 101, 6647-6652.
26. Hauck, C. R., Hsia, D. A., Ilic, D. and Schlaepfer, D. D. (2002). v-Src SH3-enhanced interaction with focal adhesion kinase at beta 1 integrin-containing invadopodia promotes cell invasion. J. Biol. Chem. 277, 12487-12490.
27. Henley, J. R. and McNiven, M. A. (1996). Association of a dynamin-like protein with the Golgi apparatus in mammalian cells. J. Cell Biol. 133, 761-775.
28. Huang, C., Ni, Y., Wang, T., Gao, Y., Haudenschild, C. C. and Zhan, X. (1997). Down-regulation of the filamentous actin cross-linking activity of cortactin by Src-mediated tyrosine phosphorylation. J. Biol. Chem. 272, 13911-13915.
29. Huang, C., Liu, J., Haudenschild, C. C. and Zhan, X. (1998). The role of tyrosine phosphorylation of cortactin in the locomotion of endothelial cells. J. Biol. Chem. 273, 25770-25776.
30. Hui, R., Ball, J. R., Macmillan, R. D., Kenny, F. S., Prall, O. W., Campbell, D. H., Cornish, A. L., McClelland, R. A., Daly, R. J., Forbes, J. F. et al. (1998). EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival. Oncogene 17, 1053-1059.
31. Kelly, T., Mueller, S. C., Yeh, Y. and Chen, W. T. (1994). Invadopedia promote proteolysis of a wide variety of extracellular matrix proteins. J. Cell. Physiol. 158, 299-308.
32. Kolch, W. (2005). Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat. Rev. Mol. Cell Biol. 6, 827-837.
33. Kozlowski, J. M., Hart, I. R., Fidler, I. J. and Hanna, N. (1984). A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice. J. Natl. Cancer Inst. 72, 913-917.
34. Krueger, E. W., Orth, J. D., Cao, H. and McNiven, M. A. (2003). A dynamin-cortactin-Arp2/3 complex mediates actin reorganization in growth factor-stimulated cells. Mol. Biol. Cell 14, 1085-1096.
35. Kumar, R., Gururaj, A. E. and Barnes, C. J. (2006). p21-activated kinases in cancer. Nat. Rev. Cancer 6, 459-471.
36. Li, Y., Liu, J. and Zhan, X. (2000). Tyrosine phosphorylation of cortactin is required for H2O2-mediated injury of human endothelial cells. J. Biol. Chem. 275, 37187-37193.
37. Li, Y., Tondravi, M., Liu, J., Smith, E., Haudenschild, C. C., Kaczmarek, M. and Zhan, X. (2001). Cortactin potentiates bone metastasis of breast cancer cells. Cancer Res. 61, 6906-6911.
38. Mao, X., Orchard, G., Lillington, D. M., Russell-Jones, R., Young, B. D. and Whittaker, S. J. (2003). Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas. Blood 101, 1513-1519.
39. Martin, K. H., Jeffery, E. D., Grigera, P. R., Shabanowitz, J., Hunt, D. F. and Parsons, J. T. (2006). Cortactin phosphorylation sites mapped by mass spectrometry. J. Cell Sci. 119, 2851-2853.
40. Martinez-Quiles, N., Ho, H. Y., Kirschner, M. W., Ramesh, N. and Geha, R. S. (2004). Erk/Src phosphorylation of cortactin acts as a switch on-switch off mechanism that controls its ability to activate N-WASP. Mol. Cell. Biol. 24, 5269-5280.
41. McNiven, M. A., Kim, L., Krueger, E. W., Orth, J. D., Cao, H. and Wong, T. W. (2000). Regulated interactions between dynamin and the actin-binding protein cortactin modulate cell shape. J. Cell Biol. 151, 187-198.
42. Mizutani, K., Miki, H., He, H., Marutta, H. and Takenawa, T. (2002). Essential role of neural Wiskott-Aldrich syndrome protein in podosome formation and degradation of extracellular matrix in sre-transformed fibroblasts. Cancer Res. 62, 669-674.
43. Monsky, W. L., Lin, C. Y., Aoyama, A., Kelly, T., Akiyama, S. K., Mueller, S. C. and Chen, W. T. (1994). A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells. Cancer Res. 54, 5702-5710.
44. Mueller, S. C. and Chen, W. T. (1991). Cellular invasion into matrix heads: localization of beta 1 integrins and fibronectin to the invadopodia. J. Cell Sci. 99, 213-225.
45. Mueller, S. C., Yeh, Y. and Chen, W. T. (1992). Tyrosine phosphorylation of membrane proteins mediates cellular invasion by transformed cells. J. Cell Biol. 119, 1309-1325.
46. Nakahara, H., Howard, L., Thompson, E. W., Sato, H., Seiki, M., Yeh, Y. and Chen, W. T. (1997). Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. Proc. Natl. Acad. Sci. USA 94, 7959-7964.
47. Olazabal, I. M. and Machesky, L. M. (2001). Abp1p and cortactin, new "hand-holds" for actin. J. Cell Biol. 154, 679-682.
48. Patel, A. S., Schechter, G. L., Wasilenko, W. J. and Somers, K. D. (1998). Overexpression of EMS1/cortactin in NIH3T3 fibroblasts causes increased cell motility and invasion in vitro. Oncogene 16, 3227-3232.
49. Pollard, T. D. (2003). The cytoskeleton, cellular motility and the reductionist agenda. Nature 422, 741-745.
50. Rasmussen, H. S. and McCann, P. P. (1997). Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat. Pharmacol. Ther. 75, 69-75.
51. Schafer, D. A. (2002). Coupling actin dynamics and membrane dynamics during endocytosis. Curr. Opin. Cell Biol. 14, 76-81.
52. Schafer, D. A., D'Souza-Schorey, C. and Cooper, J. A. (2000). Actin assembly at membranes controlled by ARF6. Traffic 1, 892-903.
53. Schafer, D. A., Weed, S. A., Binns, D., Karginov, A. V., Parsons, J. T. and Cooper, J. A. (2002). Dynamin2 and cortactin regulate actin assembly and filament organization. Curr. Biol. 12, 1852-1857.
54. Schrand, P., Schwerdtfeger, G., Burkhalter, F., Raggi, A., Schmidt, D., Ruffalo, T., King, W., Wilber, K., Mihatsch, M. J. and Moch, H. (2003). Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma. Am. J. Pathol. 163, 985-992.
55. Schuuring, E. (1995). The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes - a review. Gene 159, 83-96.
56. Tague, S. E., Muralidharan, V. and D'Souza-Schorey, C. (2004). ADP-ribosylation factor 6 regulates tumor cell invasion through the activation of the MEK/ERK signaling pathway. Proc. Natl. Acad. Sci. USA 101, 9671-9676.
57. Uruno, T., Liu, J., Zhang, P., Fan, Y., EgUe, C., Li, R., Mueller, S. C. and Zhan, X. (2001). Activation of Arp2/3 complex-mediated actin polymerization by cortactin. Nat. Cell Biol. 3, 259-266.
58. van Rossum, A. G., de Graaf, J. H., Schuuring-Scholtes, E., Kluim, P. M., Fan, Y. X., Zhan, X., Moolenaar, W. H. and Schuuring, E. (2003). Alternative splicing of the actin binding domain of human cortactin affects cell migration. J. Biol. Chem. 278, 45672-45679.
59. Vidal, C., Geny, B., Melle, J., Jandrot-Perrus, M. and Fontenay-Roupie, M. (2002). Cdc42/Rac1-dependent activation of the p21-activated kinase (PAK) regulates human platelet lamellipodia spreading: implication of the cortical-actin binding protein cortactin. Blood 100, 4462-4469.
60. Vuori, K. and Ruoslahti, E. (1995). Tyrosine phosphorylation of p130Cas and cortactin accompanies integrin-mediated cell adhesion to extracellular matrix. J. Biol. Chem. 270, 22259-22262.
61. Weaver, A. M., Karginov, A. V., Kinley, A. W., Weed, S. A., Li, Y., Parsons, J. T. and Cooper, J. A. (2001). Cortactin promotes and stabilizes Arp2/3-induced actin filament network formation. Curr. Biol. 11, 370-374.
62. Weaver, A. M., Heuser, J. E., Karginov, A. V., Lee, W. L., Parsons, J. T. and Cooper, J. A. (2002). Interaction of cortactin and N-WASp with Arp2/3 complex. Curr. Biol. 12, 1270-1278.
63. Weaver, A. M., Young, M. E., Lee, W. L. and Cooper, J. A. (2003). Integration of signals to the Arp2/3 complex. Curr. Opin. Cell Biol. 15, 23-30.
64. Webb, B. A., Zhou, S., Eves, R., Shen, L., Jia, L. and Mak, A. S. (2006). Phosphorylation of cortactin by p21-activated kinase. Arch. Biochem. Biophys. 456, 183-193.
65. Webb, B. A., Jia, L., Eves, R. and Mak, A. S. (2007). Dissecting the functional domain requirements of cortactin in invadopodia formation. Eur. J. Cell Biol. 86, 189-206.
66. Weed, S. A. and Parsons, J. T. (2001). Cortactin: coupling membrane dynamics to cortical actin assembly. Oncogene 20, 6418-6434.
67. Weed, S. A., Karginov, A. V., Schafer, D. A., Weaver, A. M., Kinley, A. W., Cooper, J. A. and Parsons, J. T. (2000). Cortactin localization to sites of actin assembly in lamellipodia requires interactions with F-actin and the Arp2/3 complex. J. Cell Biol. 151, 29-40.
68. Wu, H. and Parsons, J. T. (1993). Cortactin, an 80/85-kilodalton pp60src substrate, is a filamentous actin-binding protein enriched in the cell cortex. J. Cell Biol. 120, 1417-1426.
69. Wu, H., Reynolds, A. B., Kanner, S. B., Vines, R. R. and Parsons, J. T. (1991). Identification and characterization of a novel cytoskeleton-associated pp60src substrate. Mol. Cell. Biol. 11, 5113-5124.
70. Yamaguchi, H., Lorenz, M., Kempiak, S., Sarmiento, C., Coniglio, S., Symons, M., Segall, J., Eddy, R., Miki, H., Takenawa, T. et al. (2005). Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin. J. Cell Biol. 168, 441-452.
71. Zhan, X., Hu, X., Hampton, B., Burgess, W. H., Friesel, R. and Maciag, T. (1993). Murine cortactin is phosphorylated in response to fibroblast growth factor-1 on tyrosine residues late in the G1 phase of the BALB/c 3T3 cell cycle. J. Biol. Chem. 268, 24427-24431.
72. Zhao, Z. S. and Manser, E. (2005). PAK and other Rho-associated kinases - effectors with surprisingly diverse mechanisms of regulation. Biochem. J. 386, 201-214.
73. Zhao, Z. S., Manser, E., Chen, X. Q., Chong, C., Leung, T. and Lim, L. (1998). A conserved negative regulatory region in alphaPAK: inhibition of PAK kinases reveals their morphological roles downstream of Cdc42 and Rac1. Mol. Cell. Biol. 18, 2153-2163.
74. Zhu, J., Yu, D., Zeng, X. C., Zhou, K. and Zhan, X. (2007). Receptor-mediated endocytosis involves tyrosine phosphorylation of cortactin. J. Biol. Chem. 282, 16086-16094.